| Code | Title | Supervisor |
|---|
| 20-01 |
Design and synthesis of DNA encoded libraries of unnatural peptides to discover specific chemical probes |
Mike Waring, Newcastle |
| 20-02 |
Development and Characterisation of Assays for Primary Human Immune Cells by High-Throughput MALDI-TOF Mass Spectrometry |
Matthias Trost, Newcastle |
| 20-03 |
Development of MRI scan methods to image inhaled fluorocarbon gases as biomarkers of lung structure and function |
Pete Thelwall, Newcastle |
| 20-04 |
Harnessing Computational and Structural Biology Platforms for Drug Discovery |
Daniel Cole, Newcastle |
| 20-05 |
Cell-permeable cyclic peptide library generation for target-based screening |
Akane Kawamura, Newcastle |
| 20-06 |
CRISPR Screen Multiplexing for Uncharacterised Region Function (SMURF) |
Steve Wedge, Newcastle |
| 20-07 |
Molecular cancer therapeutics activated by radioisotope-generated Cerenkov radiation |
James Knight, Newcastle |
| 20-08 |
Developing New Tools for the Chemical Diversification of Peptide Scaffolds |
Steven Cobb, Durham |
| 20-09 |
Unravelling the mysteries of retinoid signalling |
Ehmke Pohl, Durham |
| 20-10 |
From Fragment-Screening to Fragment-Growing –New Strategies for Drug Discovery |
Ehmke Pohl, Durham |
| 20-11 |
Developing reliable ab-inito software for the interpretation of protein structure from BioSaxs data |
Chris Prior, Durham |
| 20-12 |
Harnessing Reactive Phosphorylating Agents for Peptide Bioconjugations |
David Hodgson, Durham |
| 20-13 |
Droplet-Membrane Mutual Remodeling: A Novel Physical Mechanism in Autophagy and Nuclear Envelope Assembly |
Halim Kusumaatmaja, Durham |
| 20-14 |
Platform Technology to Enhance the Growth of Human Tissues In Vitro for Use in Biomedical Research and the Assessment of New Molecular Entities |
Stefan Przyborski, Durham
|
